Literature DB >> 8476624

High-cost, high-tech medicine: are we getting our money's worth?

K J Tuman1, A D Ivankovich.   

Abstract

Increasingly stringent fiscal restraints on the spending for health care, driven by the scarcity of health resources, has introduced a need to apply cost containment measures to nearly all aspects of medical care. Intelligent cost containment measures must include application of disciplined logic to the decision making process of when to use high-tech, high-cost interventions. Such decision making depends upon knowledge of the basic concepts of economic and cost-benefit analyses, outcome (benefit) studies, and some principles of decision-threshold analysis. These basic principles are reviewed, and the potential impact of application of strategies for cost containment in the operating room and the intensive care unit is discussed.

Mesh:

Year:  1993        PMID: 8476624     DOI: 10.1016/0952-8180(93)90148-8

Source DB:  PubMed          Journal:  J Clin Anesth        ISSN: 0952-8180            Impact factor:   9.452


  4 in total

1.  Anaesthesia drug cost, control and utilization in Canada.

Authors:  G S Kantor; F Chung
Journal:  Can J Anaesth       Date:  1996-01       Impact factor: 5.063

2.  The cost of anaesthesia.

Authors:  C J Eagle; S Kryski
Journal:  Can J Anaesth       Date:  1994-03       Impact factor: 5.063

3.  Price stickers do not alter drug usage.

Authors:  J C Horrow; H Rosenberg
Journal:  Can J Anaesth       Date:  1994-11       Impact factor: 5.063

Review 4.  Technology assessment of anaesthesia monitors: problems and future directions.

Authors:  R J Byrick; M M Cohen
Journal:  Can J Anaesth       Date:  1995-03       Impact factor: 5.063

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.